CalciMedica, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from CalciMedica, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Self-Funding Ratio: Over the last 3 years operating cash was negative while the company kept spending on investment (capex). Lower than 96% of Healthcare companies in United States.
- Shareholder Slice Ratio: Share count rose 896% in 3 years, so each share's slice of the company became smaller. Bigger rise in share count than 90% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 0 of the last 3 years; profit grew in 1 of 3. Less steady than 86% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
-597.0×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 96% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 1/3Sales grew in 0 of the last 3 years; profit grew in 1 of 3.
Less steady than 86% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-16.9×Operating cash was negative last year, while some debt falls due within a year.
Lower than 51% of Healthcare companies in United States.
Cash Cushion Ratio
+42%Cash, after subtracting all debt, equals 42% of its market value (net cash).
Higher than 75% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
CalciMedica, Inc. made a loss over the last year. CalciMedica, Inc. owes $0.72 for every $1 it owns. CalciMedica, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossCalciMedica, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.42The share price is 1.42 times CalciMedica, Inc.'s book value per share, lower than 69% of Healthcare companies in United States.
Market cap
$8 MThe total market value of all of CalciMedica, Inc.'s shares at today's price (share price × number of shares), smaller than 90% of Healthcare companies in United States. PosiCap size class: Nano Cap.
Net worth (book value)
$6 MWhat CalciMedica, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.81Net worth divided by the number of shares. The share price of $1.15 is 1.4 times this, which is the P/B above.
Return on equity (ROE)
-365.7%CalciMedica, Inc. lost 365.7% of its shareholders' money over the last year, lower than 91% of Healthcare companies in United States.
Owes vs Owns
0.72×CalciMedica, Inc. owes $0.72 for every $1 it owns (moderate), higher than 72% of Healthcare companies in United States.
Dividend yield
NoneCalciMedica, Inc. does not currently pay a dividend.
Profit growth
LossCalciMedica, Inc. made a loss in each of the last two years.
Interest cover
Not coveredCalciMedica, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashCalciMedica, Inc. held $3 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For CalciMedica, Inc.: $8 M ÷ $6 M (30 Jun 2026) = 1.4.
What is CalciMedica, Inc.'s return on equity?
CalciMedica, Inc. lost 365.7% of its shareholders' money over the last year, lower than 91% of Healthcare companies in United States.
How much does CalciMedica, Inc. owe compared with what it owns?
CalciMedica, Inc. owes $0.72 for every $1 it owns (moderate), higher than 72% of Healthcare companies in United States.
Does CalciMedica, Inc. pay a dividend?
No. CalciMedica, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.